The largest database of trusted experimental protocols

6 protocols using tws119

1

Podocyte Response to IL-17 and Wnt Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Podocytes were cultured at 37°C in a water-saturated atmosphere with 5% CO2 for 5 days before initiation of experiments. Podocytes were separately exposed to Dkk1 (R&D Systems) or NS-398 (Sigma Chemical Co., St Louis, MO) in serum-free DMEM containing peptidase inhibitors (1 μM phosphoramidon, 4 μg/mL bacitracin and 1 μM captopril; Sigma) for 15 minutes at 37°C in a water-saturated atmosphere with 5% CO2. The cells were then treated with IL-17 and continuously stimulated with TWS119 (Cayman Chemical, Ann Arbor, MI) or Wnt-3a (R&D Systems) for 8, 12, or 24 hours in DMEM at 37°C. Podocytes were treated with different concentrations of IL-17.
+ Open protocol
+ Expand
2

Screening of Small Molecule Library

Check if the same lab product or an alternative is used in the 5 most similar protocols
The 1040 compounds used for the small molecule screen were from the Prestwick Chemical Library (Illkirch, France). The following compounds were obtained from Cayman Chemical (Ann Arbor, MI): TWS119 (#10011251), ipsapirone (#22075), bromocriptine (#14598), urapidil (#29004), trimipramine (#15921), dichlorphenamide (#23658), nimesulide (#70640), and mesalamine (#70265). Lithium chloride (LiCl) was obtained from Sigma (St. Louis, MO, #62476), lithium acetate was obtained from Aldrich Chemical Company (Milwaukee WI, #21,319–5), and bortezomib (BTZ) was obtained from EMD Millipore (#179324-69-7).
+ Open protocol
+ Expand
3

Generating Tscm Cells via Wnt Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
To generate the Tscm cells in vitro, Wnt signaling was activated in T cells by GSK-3β blockade with the inhibitor TWS119. Briefly, peripheral blood mononuclear cells (PBMCs) were isolated from peripheral blood of RCC patients by Ficoll density gradient centrifugation. CD8+ and naïve CD8+ T cells were purified from PBMCs using the EasySepTM human CD8+ T cell enrichment kit (STEMCELL, 19053) and the EasySepTM human naïve CD8+ T cell enrichment kit (STEMCELL, 19158), respectively, according to the manufacturer’s instructions. PBMCs, CD8+, or naïve CD8+ T cells were stimulated by ɑ-CD3/CD28 beads (Invitrogen, 11452D) at a bead-to-cell ratio of 1:1 and 300 IU/mL IL-2 (PeproTech, AF-200-02) in the presence of 5 μM TWS119 (Cayman Chemical, 10011251) for 7 days. Culture medium (10% RPMI1640) containing TWS119 and IL-2 were supplemented on day 3 and 5.
+ Open protocol
+ Expand
4

T cell Expansion and Pathway Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
T cells were cultured in RPMI-1640 supplemented with 8% heat inactivated, pooled human serum or 10% foetal calf serum, 50 IU/ml penicillin, 50 μg/ml streptomycin, 4 mM l-glutamine, 1% (v/v) non-essential amino acids and 50 μM 2-mercaptoethanol. Sorted TN cells were primed with anti-CD3/CD28 beads (Invitrogen) or OKT3/anti-CD28 antibody (in house, derived from hybridoma cells) and IL-2 (Proleukin®, Roche Pharma AG). Pathway interfering drugs were TWS119 (Cayman Chemical), rapamycin (LC Laboratories), PP242 (Chemdea), KU-0063794 (Chemdea), Indirubin-3-monoxime (Sigma-Aldrich), SB216763 (Sigma-Aldrich) and recombinant human Wnt3A (R&D Systems).
+ Open protocol
+ Expand
5

Substance P Regulation in Cultured DRG Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The isolated DRG cells from adult Wistar rats (6–9 weeks of age) were cultured at 37°C in a water-saturated atmosphere with 5% CO2 for 5 days before the initiation of experiments [3 (link)]. Next, the DRG cells (5–6 DRGs/35 mm dish) were separately exposed to Dkk1 (R&D Systems, Minneapolis, MN 55413, USA) or NS-398 (Sigma Chemical Co., St Louis, MO, USA) in serum-free DMEM containing peptidase inhibitors (1 μM phosphoramidon, 4 μg/ml bacitracin and 1 μM captopril; Sigma) for 15 min at 37°C in a water-saturated atmosphere with 5% CO2. Thereafter, the cells pretreated with various drugs were continuously stimulated with TWS119 (Cayman Chemical, Ann Arbor, MI) or Wnt-3a (R&D Systems) for 1, 6, 24 or 48 h in DMEM at 37°C. The DRG cells treated by peptidase inhibitors alone were used as a control. The substance P content in the cultured rat DRG cells was measured using a highly sensitive radioimmunoassay as previously described [13 (link)].
+ Open protocol
+ Expand
6

Modulation of Cellular Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following reagents were purchased: bortezomib (Santa Cruz Biotech), cycloheximide (CHX) (FisherThermo Scientific), benzyl 2-acetamido-2-deoxy-α-D-galactopyranoside (BADGP) (Sigma), leupeptin (Sigma), PMA (Sigma), tunicamycin (Sigma), recombinant IFN-γ (Biolegend), TWS119 (Cayman Chemical). From CalBiochem: MG132, protein kinase G inhibitor, KN-93, bisindolylmaleimide I, ML-7, staurosporine, H-89. From TOCRIS Biosciences: U0126, SB 202190, SP 600125.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!